145 related articles for article (PubMed ID: 33990203)
1. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.
Song D; Guo M; Xu S; Song X; Bai B; Li Z; Chen J; An Y; Nie Y; Wu K; Wang S; Zhao Q
J Exp Clin Cancer Res; 2021 May; 40(1):170. PubMed ID: 33990203
[TBL] [Abstract][Full Text] [Related]
2. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.
Santos LS; Silva VR; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
Cell Death Dis; 2023 Dec; 14(12):832. PubMed ID: 38102125
[TBL] [Abstract][Full Text] [Related]
3. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
Liu XS; Chen YX; Wan HB; Wang YL; Wang YY; Gao Y; Wu LB; Pei ZJ
Sci Rep; 2024 Feb; 14(1):4042. PubMed ID: 38369589
[TBL] [Abstract][Full Text] [Related]
4. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
5. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis.
Cui Q; Yin K; Zhang X; Ye P; Chen X; Chao J; Meng H; Wei J; Roeth D; Li L; Qin Y; Sun G; Zhang M; Klein J; Huynhle M; Wang C; Zhang L; Badie B; Kalkum M; He C; Yi C; Shi Y
Nat Cancer; 2021 Sep; 2(9):932-949. PubMed ID: 35121864
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Is Dependent on tRNA Pseudouridylation.
Cancer Discov; 2021 Oct; 11(10):2367. PubMed ID: 34452948
[TBL] [Abstract][Full Text] [Related]
7. pH-regulated chaperone function of cyanobacterial Hsp90 and Hsp70: implications for light/dark regulation.
Akter T; Nakamoto H
J Biochem; 2021 Dec; 170(4):463-471. PubMed ID: 33993259
[TBL] [Abstract][Full Text] [Related]
8. Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism.
Liu J; Wu XD; Li W; Yuan Z; Yang K; Zhao QS
Bioorg Chem; 2021 Jul; 112():104963. PubMed ID: 33991836
[TBL] [Abstract][Full Text] [Related]
9. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
[TBL] [Abstract][Full Text] [Related]
10. PUS7: a targetable epitranscriptomic regulator of glioblastoma growth.
Zhang DY; Ming GL; Song H
Trends Pharmacol Sci; 2021 Dec; 42(12):976-978. PubMed ID: 34657723
[TBL] [Abstract][Full Text] [Related]
11. Higher expression of pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis.
Zhang G; Zhu Y; Tan Y; Chen B; Shan S; Zhang G; Lu J
J Cardiothorac Surg; 2023 Jul; 18(1):222. PubMed ID: 37420297
[TBL] [Abstract][Full Text] [Related]
12. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
[TBL] [Abstract][Full Text] [Related]
13. Understanding the sources of errors in
Wang R; Alvarez DA; Crouch BT; Pilani A; Lam C; Zhu C; Hughes P; Katz D; Haystead T; Ramanujam N
Biomed Opt Express; 2021 Apr; 12(4):2299-2311. PubMed ID: 33996230
[TBL] [Abstract][Full Text] [Related]
14. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
[TBL] [Abstract][Full Text] [Related]
15. The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface.
Guegueniat J; Halabelian L; Zeng H; Dong A; Li Y; Wu H; Arrowsmith CH; Kothe U
Nucleic Acids Res; 2021 Nov; 49(20):11810-11822. PubMed ID: 34718722
[TBL] [Abstract][Full Text] [Related]
16. Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique.
Martinez Campos C; Tsai K; Courtney DG; Bogerd HP; Holley CL; Cullen BR
RNA; 2021 Nov; 27(11):1400-1411. PubMed ID: 34376564
[TBL] [Abstract][Full Text] [Related]
17. PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β-catenin pathway.
Zhang Q; Fei S; Zhao Y; Liu S; Wu X; Lu L; Chen W
Mol Carcinog; 2023 Feb; 62(2):160-173. PubMed ID: 36222184
[TBL] [Abstract][Full Text] [Related]
18. Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.
Kan G; Wang Z; Sheng C; Chen G; Yao C; Mao Y; Chen S
Adv Sci (Weinh); 2021 May; 8(10):2004344. PubMed ID: 34026451
[TBL] [Abstract][Full Text] [Related]
19. RNA modifications in cancer.
Tang Q; Li L; Wang Y; Wu P; Hou X; Ouyang J; Fan C; Li Z; Wang F; Guo C; Zhou M; Liao Q; Wang H; Xiang B; Jiang W; Li G; Zeng Z; Xiong W
Br J Cancer; 2023 Aug; 129(2):204-221. PubMed ID: 37095185
[TBL] [Abstract][Full Text] [Related]
20. Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma.
Jin Z; Song M; Wang J; Zhu W; Sun D; Liu H; Shi G
Front Genet; 2022; 13():944681. PubMed ID: 36437949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
